Forbes July 5, 2022
Brian Bushard


An “all-in-one” vaccine currently in development could protect people from future Covid-19 variants, as well as SARS, MERS and new strains of other coronaviruses from other animals, a study by researchers at the California Institute of Technology found.


The study, published Thursday in the journal Science, was done by scientists at Caltech and the University of Oxford who are working on developing the mosaic-8 vaccine, which aims to offer protection to a variety of coronaviruses

Researchers tested mice vaccinated with the Covid-19 shots as well as the mosaic-8 vaccine and found unvaccinated mice died when infected with SARS or Covid-19, while mice vaccinated only against Covid-19 survived the virus, but not SARS, and mice given the mosaic-8...

Today's Sponsors

Oliver Wyman
Patient Bond

Today's Sponsors

Oliver Wyman

Today's Sponsor

Patient Bond

Topics: Biotechnology, Govt Agencies, Healthcare System, Patient / Consumer, Pharma / Biotech, Provider, Public Health / COVID, Survey / Study, Trends
What Causes Long COVID?
Long COVID cardiac studies: More questions than answers.
Moderna’s Omicron Booster Approved In The U.K. In World First
Digital health app interest increases during pandemic
UK first to approve Moderna’s Omicron booster jab